Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neostigmine Dosing Strategies for Rocuronium Reversal
NCT03058263Phase 2Completed
- Sponsor
- Universitas Indonesia
- Start
- Oct 2016
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of neostigmine in neuromuscular blockade (NMB), sponsored by Universitas Indonesia. Started Oct 2016; status: completed.
02
Drugs
neostigmine
03
Conditions
neuromuscular blockade (NMB)
Beyond the preview
Go deeper on NCT03058263.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03058263.